Within two months of being announced, in-person tickets to the Wellington symposium sold out – a strong signal, organisers say, of growing public appetite for a deeper conversation about the ...

As umami is more of a newcomer to the taste world, many of us aren't quite sure what it is, and whether it's different from ...

The agricultural economy was the backbone of wealth in ancient Greece. Food brought people together, whether in smaller groups at a wine-drinking symposium or the entire community in a sacrificial ...

Natasha’s Foundation has opened applications for Natasha’s Prize, a £10 million research award aimed at finding out how to ...

Research suggests a potential topical treatment for common skin cancers, squamous cell and basal cell carcinoma Findings will be presented at 2026 RNA Therapeutics Symposium June 24-26SAN ...

We are told the natural world is ‘breaking down’. But forests don’t work like aeroplanes or human hearts ...

The FDA's new rules mean you can no longer just submit basic health data codes, since the most critical patient details are hidden in clinical notes.

(NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE ® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the ...

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...

U.S. President Donald Trump threatened to impose new tolls in the Strait of Hormuz last weekend, sparking worries that the ...

EBR Systems believes its wireless Wise pacemaker can transform treatment for heart failure patients who have limited options.

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of ...